Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, assessing icotrokinra in treating plaque ...

Medically reviewed by Katlein Franca, MD Nail psoriasis and onychomycosis (nail fungus) are both conditions that can discolor ...

Urging people to look at their toenails, Sheena Bagga, a Pharmacist prescriber at LloydsPharmacy Online Doctor, has shared ...

J&J announces positive data from phase 3 ICONIC-TOTALa study of icotrokinra to treat scalp and genital psoriasis: Spring House, Pennsylvania Monday, May 12, 2025, 11:00 Hrs [IST] ...

Our toes can tell us a lot about our health and can give us clues to a range of issues from nutritional deficiencies, to ...

Data from a late-stage study shows that treatment with JNJ's icotrokinra helps achieve significant skin clearance in ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Johnson & Johnson (J&J) and Protagonist Therapeutics’ investigational oral peptide icotrokinra (JNJ-2113) has been associated ...

Findings also showed that among the small subset of patients with hand and/or foot psoriasis, 42% of icotrokinra-treated patients achieved a hand and/or foot Physician’s Global Assessment score ...

Turmeric, a common spice, has been used in Eastern medicine for centuries. Studies are now examining the benefits of yellow ...